Cytokine & growth factor reviewsHumansImmunotherapyAdoptiveReceptorsChimeric Antigen
The intersection of CAR-T immunotherapy with emerging technologies.
Begüm Coşar, Pelin Kılıç, Özlem Darcansoy İşeri
Published: 202510.1016/j.cytogfr.2025.11.001
Abstract
Chimeric antigen receptor (CAR) T-cell (CAR-T) therapy is a transformative modality in cancer immunotherapy that employs genetically engineered T-cells to eliminate malignant cells selectively. Its efficacy and limitations are governed by cytokine- a…
Preview only. Read the full abstract at the source